{"id":"https://openalex.org/W2006490048","doi":"https://doi.org/10.5539/cco.v2n2p55","title":"Molecular Screening for T315I and F317L Resistance Mutations in Iraqi Chronic Myeloid Leukemia Non-Responders Patients to Imatinib","display_name":"Molecular Screening for T315I and F317L Resistance Mutations in Iraqi Chronic Myeloid Leukemia Non-Responders Patients to Imatinib","publication_year":2013,"publication_date":"2013-09-30","ids":{"openalex":"https://openalex.org/W2006490048","doi":"https://doi.org/10.5539/cco.v2n2p55","mag":"2006490048"},"language":"en","primary_location":{"id":"doi:10.5539/cco.v2n2p55","doi":"https://doi.org/10.5539/cco.v2n2p55","is_oa":true,"landing_page_url":"https://doi.org/10.5539/cco.v2n2p55","pdf_url":"https://ccsenet.org/journal/index.php/cco/article/download/29552/18187","source":{"id":"https://openalex.org/S2764831629","display_name":"Cancer and Clinical Oncology","issn_l":"1927-4858","issn":["1927-4858","1927-4866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310322531","host_organization_name":"Canadian Center of Science and Education","host_organization_lineage":["https://openalex.org/P4310322531"],"host_organization_lineage_names":["Canadian Center of Science and Education"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer and Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ccsenet.org/journal/index.php/cco/article/download/29552/18187","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085545374","display_name":"Maysaa Abdul Razzaq Dhahi","orcid":"https://orcid.org/0000-0003-3436-8084","observed_orcids":["https://orcid.org/0000-0003-3436-8084"]},"institutions":[{"id":"https://openalex.org/I56409017","display_name":"Nahrain University","ror":"https://ror.org/05v2p9075","country_code":"IQ","type":"education","lineage":["https://openalex.org/I56409017"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Maysaa Abdul Razzaq Dhahi","raw_affiliation_strings":["Microbiology Dept , College of Medicine , Al-Nahrain University , Iraq","Baghdad-Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Microbiology Dept , College of Medicine , Al-Nahrain University , Iraq","institution_ids":["https://openalex.org/I56409017"]},{"raw_affiliation_string":"Baghdad-Iraq","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005603116","display_name":"Bassam Francis Matti","orcid":"https://orcid.org/0009-0009-6981-7426","observed_orcids":["https://orcid.org/0009-0009-6981-7426"]},"institutions":[{"id":"https://openalex.org/I56409017","display_name":"Nahrain University","ror":"https://ror.org/05v2p9075","country_code":"IQ","type":"education","lineage":["https://openalex.org/I56409017"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Bassam F. Matti","raw_affiliation_strings":["Baghdad Teaching Hospitalet, Hematology Unite, Iraq","Microbiology (Molecular biology) , Microbiology Dept. , College of Medicine , Al-Nahrain University , PO Box 70062 , Baghdad , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baghdad Teaching Hospitalet, Hematology Unite, Iraq","institution_ids":[]},{"raw_affiliation_string":"Microbiology (Molecular biology) , Microbiology Dept. , College of Medicine , Al-Nahrain University , PO Box 70062 , Baghdad , Iraq","institution_ids":["https://openalex.org/I56409017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112164166","display_name":"Shahlaa Fadel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15873915","display_name":"Mustansiriyah University","ror":"https://ror.org/05s04wy35","country_code":"IQ","type":"education","lineage":["https://openalex.org/I15873915"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Shahlaa Fadel","raw_affiliation_strings":["The National Center of Hematology, Al-Mustansiriya University, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The National Center of Hematology, Al-Mustansiriya University, Iraq","institution_ids":["https://openalex.org/I15873915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"2","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9819999933242798},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.9580000042915344},{"id":"https://openalex.org/keywords/bcr-abl-mutations","display_name":"BCR-ABL mutations","score":0.8479999899864197},{"id":"https://openalex.org/keywords/second-generation-tyrosine-kinase-inhibitors","display_name":"second-generation tyrosine kinase inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/iraqi-patients","display_name":"Iraqi patients","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.8583092093467712},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.7853832244873047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7687660455703735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6577329635620117},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.637365460395813},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6337636113166809},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5070457458496094},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.47877418994903564},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43926388025283813},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.43097907304763794},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41896897554397583},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36530277132987976},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15023905038833618},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5539/cco.v2n2p55","doi":"https://doi.org/10.5539/cco.v2n2p55","is_oa":true,"landing_page_url":"https://doi.org/10.5539/cco.v2n2p55","pdf_url":"https://ccsenet.org/journal/index.php/cco/article/download/29552/18187","source":{"id":"https://openalex.org/S2764831629","display_name":"Cancer and Clinical Oncology","issn_l":"1927-4858","issn":["1927-4858","1927-4866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310322531","host_organization_name":"Canadian Center of Science and Education","host_organization_lineage":["https://openalex.org/P4310322531"],"host_organization_lineage_names":["Canadian Center of Science and Education"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer and Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.847.1829","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.847.1829","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ccsenet.org/journal/index.php/cco/article/download/29552/18187/","raw_type":"text"}],"best_oa_location":{"id":"doi:10.5539/cco.v2n2p55","doi":"https://doi.org/10.5539/cco.v2n2p55","is_oa":true,"landing_page_url":"https://doi.org/10.5539/cco.v2n2p55","pdf_url":"https://ccsenet.org/journal/index.php/cco/article/download/29552/18187","source":{"id":"https://openalex.org/S2764831629","display_name":"Cancer and Clinical Oncology","issn_l":"1927-4858","issn":["1927-4858","1927-4866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310322531","host_organization_name":"Canadian Center of Science and Education","host_organization_lineage":["https://openalex.org/P4310322531"],"host_organization_lineage_names":["Canadian Center of Science and Education"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer and Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2006490048.pdf","grobid_xml":"https://content.openalex.org/works/W2006490048.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1971147813","https://openalex.org/W1975975368","https://openalex.org/W1980571402","https://openalex.org/W1994309500","https://openalex.org/W1995670055","https://openalex.org/W1997360163","https://openalex.org/W2003973314","https://openalex.org/W2015616444","https://openalex.org/W2039021265","https://openalex.org/W2048258225","https://openalex.org/W2051465464","https://openalex.org/W2051728915","https://openalex.org/W2054251966","https://openalex.org/W2055502046","https://openalex.org/W2065514651","https://openalex.org/W2065551889","https://openalex.org/W2074198797","https://openalex.org/W2076736727","https://openalex.org/W2078327579","https://openalex.org/W2087724329","https://openalex.org/W2091423586","https://openalex.org/W2092606584","https://openalex.org/W2110648386","https://openalex.org/W2115121795","https://openalex.org/W2124196948","https://openalex.org/W2132759526","https://openalex.org/W2134748741","https://openalex.org/W2136065656","https://openalex.org/W2136373950","https://openalex.org/W2137644376","https://openalex.org/W2151486690","https://openalex.org/W2166654361","https://openalex.org/W2170527434","https://openalex.org/W2981507231","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2751600561","https://openalex.org/W2142243033","https://openalex.org/W2980287658","https://openalex.org/W7097484585","https://openalex.org/W2524777562","https://openalex.org/W2742947749","https://openalex.org/W2955223521","https://openalex.org/W4385775850","https://openalex.org/W2581024504","https://openalex.org/W1446283465"],"abstract_inverted_index":{"The":[0,65,93,229],"development":[1],"of":[2,14,44,53,61,67,82,84,95,103,173,218,277,294],"Imatinib":[3],"Mesylate":[4],"(IM),":[5],"the":[6,31,37,42,171,275,292],"first":[7],"generation":[8,69],"specific":[9,295],"tyrosine":[10],"kinase":[11],"inhibitor":[12],"(TKI)":[13],"BCR-ABL,":[15],"has":[16,56,301],"had":[17],"a":[18],"major":[19],"impact":[20],"in":[21,59,75,91,130,179,198,238,287],"patients":[22,76,134,147,162,178,197,216,221,289],"with":[23,41,77,137,299],"Chronic":[24],"Myeloid":[25],"Leukemia":[26],"(CML),":[27],"establishing":[28],"IM":[29,49,62,78,87,123,131,192,201,214,240,300],"as":[30,119,204],"standard":[32],"therapy":[33],"for":[34,282],"CML.":[35,92],"Despite":[36],"clinical":[38],"success":[39],"obtained":[40],"use":[43],"IM,":[45],"primary":[46],"resistance":[47,85,108],"to":[48,86,100,109,122,128,158,224,249,261,269],"and":[50,114,124,168,206,251,284],"molecular":[51],"evidence":[52],"persistent":[54],"disease":[55],"been":[57],"observed":[58],"20-25%":[60],"treated":[63],"patients.":[64],"existence":[66],"second":[68],"TKIs":[70],"(SGTKIs),":[71],"which":[72,105,117],"are":[73],"effective":[74],"resistance,":[79],"makes":[80],"identification":[81],"predictors":[83],"an":[88],"important":[89],"goal":[90],"aim":[94],"this":[96],"prospective":[97],"study":[98],"was":[99,236,254],"determine":[101],"prevalence":[102],"T315I,":[104],"confers":[106],"full":[107],"all":[110],"available":[111],"tyrosine-kinase":[112],"inhibitors,":[113],"F317l":[115],"mutations,":[116],"classified":[118],"resistant":[120],"mutation":[121,235,252,258,279],"dasatinib":[125],"but":[126],"sensitive":[127,139],"nilotinb,":[129],"non-responder":[132,241],"CML":[133,146,177,196,242,288],"from":[135,150,155],"Iraq":[136],"highly":[138],"Allele-Specific":[140],"Oligonucleotide-PCR":[141],"assay":[142],"(ASO-PCR).":[143],"Forty":[144],"four":[145,176],"were":[148,163,191,200,222],"recruited":[149,223],"Baghdad":[151],"Teaching":[152],"Hospitalet-Hematology":[153],"Unite":[154],"Feb.":[156,159],"2009":[157],"2013.":[160],"Those":[161],"followed":[164],"up":[165],"(hematological,":[166],"cytogenetically,":[167],"molecularly).":[169],"At":[170],"time":[172],"sampling,":[174],"thirty":[175],"advance":[180],"phase(accelerated":[181],"phase(AP)":[182],"or":[183,186],"blast":[184],"crisis(BC))":[185],"loss":[187],"their":[188],"cytogenetic":[189],"response":[190,248],"non-responders":[193,215],"while":[194],"ten":[195],"CP":[199],"responder,":[202],"considered":[203],"T315I":[205,234,283],"F317":[207],"L":[208],"mutations":[209,286],"negative":[210],"control":[211],"group.":[212],"Ten":[213],"out":[217],"those":[219],"34":[220],"SGTKIs":[225,250,296],"(Dasatinib":[226],"and/or":[227],"Nilotinib).":[228],"results":[230],"shown":[231],"that":[232],"only":[233,262],"detected":[237],"one":[239,263],"patient":[243,264],"(3%).":[244],"Although":[245],"relation":[246],"between":[247],"status":[253],"non-significance":[255],"(P=":[256],"0.100),":[257],"is":[259],"limited":[260],"who":[265],"did":[266],"not":[267],"respond":[268],"either":[270],"treatment":[271,298],"forms.":[272],"In":[273],"conclusion,":[274],"uses":[276],"bcr-abl":[278],"screening":[280],"test":[281],"F317L":[285],"may":[290],"influences":[291],"choice":[293],"after":[297],"failed.":[302]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}